Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Faculty Opinions recommendation of Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats. — Ralf Weiskirchen | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats.
RW
Shared by
Ralf Weiskirchen
Faculty Opinions recommendation of Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats.
Dataset
en
Authors
RW
Ralf Weiskirchen
MH
Martin Hennenberg
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
Ralf Weiskirchen
,
Martin Hennenberg
Dataset
Faculty Opinions recommendation of Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction.
George Perry
Discussion(0)
No comments yet. Be the first to comment.